Stock listing
Me Therapeutics Holdings, Inc.
Selected listing: METX · NEO · CAD · CA
Me Therapeutics Holdings, Inc. (Cboe Canada: METX), Health Technology. Latest release Sep 8, 2026: ME Therapeutics Advances In Vivo CAR and Therapeutic mRNA…
- Ticker
- Cboe Canada: METX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- Cboe Canada
- Currency
- CAD
About Me Therapeutics Holdings, Inc.
The company is focused on developing innovative therapeutic solutions. Me Therapeutics aims to address unmet medical needs through its research and development efforts.
Latest news from Me Therapeutics Holdings, Inc.
ME Therapeutics Advances In Vivo CAR and Therapeutic mRNA STING Programs
September 8, 2026
ME Therapeutics Closes Over-Subscribed Private Placement
July 17, 2026
ME Therapeutics Announces Private Placement
June 3, 2026
ME Therapeutics to Pitch at CSE Capital Tech Connect During Web Summit Vancouver
May 7, 2026
ME Therapeutics Provides Scientific Update on In Vivo CAR and Therapeutic mRNA Programs
April 29, 2026
Research Me Therapeutics Holdings, Inc.
Me Therapeutics Holdings, Inc. company profile
View the public company page for Me Therapeutics Holdings, Inc. on 6ix.
Me Therapeutics Holdings, Inc. news
Read company news and market updates connected to Me Therapeutics Holdings, Inc..
Me Therapeutics Holdings, Inc. investor events
Find investor webinars, events, and replay context for Me Therapeutics Holdings, Inc..
Alternate listings
METX:CSE
CA · CAD
Alternate listing for Me Therapeutics Holdings, Inc.; the primary context on this page is METX:NEO.
METXF:OTC
US · USD
Alternate listing for Me Therapeutics Holdings, Inc.; the primary context on this page is METX:NEO.
Q9T:FWB
DE · EUR
Alternate listing for Me Therapeutics Holdings, Inc.; the primary context on this page is METX:NEO.